Aim was to select naïve patients with genotype 1 chronic hepatitis C having a high probability of response to Peg-interferon+ribavirin therapy.

Andriulli, A., Nardi, A., Di Marco, V., Ippolito, A., Gavrila, C., Aghemo, A., et al. (2014). An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C. DIGESTIVE AND LIVER DISEASE, 46(9), 818-825 [10.1016/j.dld.2014.05.015].

An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C

NARDI, ALESSANDRA;DI PAOLO, DANIELE;ANGELICO, MARIO;
2014-09-01

Abstract

Aim was to select naïve patients with genotype 1 chronic hepatitis C having a high probability of response to Peg-interferon+ribavirin therapy.
set-2014
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/12 - GASTROENTEROLOGIA
English
Con Impact Factor ISI
HCV infection; Predictors of sustained virological response, Rapid virological response; Peg-interferon and ribavirin treatment; Chronic hepatitis
Andriulli, A., Nardi, A., Di Marco, V., Ippolito, A., Gavrila, C., Aghemo, A., et al. (2014). An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C. DIGESTIVE AND LIVER DISEASE, 46(9), 818-825 [10.1016/j.dld.2014.05.015].
Andriulli, A; Nardi, A; Di Marco, V; Ippolito, A; Gavrila, C; Aghemo, A; DI PAOLO, D; Squadrito, G; Grassi, E; Calvaruso, V; Valvano, M; Brancaccio, G...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
andriulli nardi.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 994.54 kB
Formato Adobe PDF
994.54 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/96815
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact